Therapeutic Advances in Cardiovascular Disease

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Register here to gain access to SAGE's 500+ Journals Online

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Margozzini, P.
Right arrow Articles by Valdés, G.
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Therapeutic Advances in Cardiovascular Disease, Vol. 1, No. 1, 83-90 (2007)
DOI: 10.1177/1753944707082716

Reviews

Review: Hypertension and the cardiometabolic syndrome in Chile: a review of concepts and consequences for the developing world

P. Margozzini

Departamento de Salud Pública, Facultad de Medicina, Pontificia Universidad Católica de Chile, Marcoleta 434, Santiago, Chile pmargoz{at}med.puc.cl

A. Rigotti

Departamento de Gastroenterología, Facultad de Medicina, Pontificia Universidad Católica de Chile, Marcoleta 367, Santiago, Chile

C. Ferreccio

Departamento de Salud Pública, Facultad de Medicina, Pontificia Universidad Católica de Chile, Marcoleta 434, Santiago, Chile

N. Quezada

Departamento de Salud Pública, Facultad de Medicina, Pontificia Universidad Católica de Chile, Marcoleta 434, Santiago, Chile

M. Garrido

Departamento de Salud Pública, Facultad de Medicina, Pontificia Universidad Católica de Chile, Marcoleta 434, Santiago, Chile

G. Valdés

Departamento de Nefrología, Facultad de Medicina, Pontificia Universidad Católica de Chile, Lira 85, Santiago, Chile

We review some recent developments regarding the concept of cardiometabolic syndrome and its relation with hypertension and overall cardiovascular disease risk. We emphasize how this new clinical entity has helped to understand multimorbidity in chronic diseases. This concept has important consequences for individual patient treatment as well as public health policy. The challenge derived from cardiovascular disease and other chronic conditions is increasing worldwide, but the highest burden is located in the developing world. Thus, new and cost-effective approaches are needed for diseases that are mainly occurring in the poorest and less educated populations. We illustrate this situation analyzing hypertension and cardiometabolic syndrome data derived from a recent national health survey in Chile.

Key Words: hypertension • metabolic syndrome • cardiometabolic syndrome • cardiovascular disease • cardiovascular risk • epidemiology.

References

  • Aguilar-Salinas, C.A. et al. (2004) High Prevalence of Metabolic Syndrome in Mexico. Arch Med Res 35: 76—81.[CrossRef][Medline] [Order article via Infotrieve]
  • Alberti, K.G. and Zimmet, P.Z. (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15: 539—555.[CrossRef][Medline] [Order article via Infotrieve]
  • Arcaro, G. et al. (2002) Insulin causes endothelial dysfunction in humans: sites and mechanisms. Circulation 105: 576—582.[Abstract/Free Full Text]
  • Balkau, B. and Charles, M.A. (1999) Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet Med 16: 442—453.[CrossRef][Medline] [Order article via Infotrieve]
  • Bergman, R.N. et al. (2007) Abdominal obesity: role in the pathophysiology of metabolic disease and cardiovascular risk. Am J Med 120(2 Suppl 1): S3—8.[Medline] [Order article via Infotrieve]
  • Cuspidi, C. et al. (2007) Age and target organ damage in essential hypertension: role of the metabolic syndrome. Am J Hypertens 20: 296—303.[CrossRef][Medline] [Order article via Infotrieve]
  • De Fronzo, R.A. et al. (1975) The effect of insulin on renal handling of sodium, potassium, calcium, and phosphate in man. J Clin Invest 55: 845—855.[Medline] [Order article via Infotrieve]
  • Despres, J.P. (2006) Is visceral obesity the cause of the metabolic syndrome? Ann Med 38: 52—63.[CrossRef][Medline] [Order article via Infotrieve]
  • Despres, J.P. and Lemieux, I. (2006) Abdominal obesity and metabolic síndrome. Nature 444: 881—887.[CrossRef][Medline] [Order article via Infotrieve]
  • Eckel, R.H. et al. (2005) The metabolic síndrome. Lancet 365: 1415—1428.[CrossRef][Medline] [Order article via Infotrieve]
  • Einhorn, D. et al. (2003) American College of Endocrinology position statement on the insulin resistance syndrome. Endocr Pract 9: 237—252.[Medline] [Order article via Infotrieve]
  • Fasce, E. et al. (1992) La hipertensión arterial en una comunidad urbana de Chile. Rev Chil Cardiol 11: 1—12.
  • Ferrario, C.M. et al. (2002) The hypertension—lipid connection: insights into the relation between angiotensin II and cholesterol in atherogenesis. Am J Med Sci 323: 17—24.[CrossRef][Medline] [Order article via Infotrieve]
  • Grundy, S.M. et al. (2004) American Heart Association; National Heart, Lung, and Blood Institute. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 109: 433—438.
  • Guo, X. ( 2005) Hypertension genes are genetic markers for insulin sensitivity and resistance. Hypertension 45: 799—803.[Abstract/Free Full Text]
  • Hall, J.E. et al. (1992) Obesity—associated hypertension. Hyperinsulinemia and renal mechanisms. Hypertension 19(1 Suppl): 145—155.
  • International Diabetes Federation (2005) The IDF consensus worldwide definition of the metabolic syndrome. Part 1: Worldwide definition for use in clinical practice. Available at http://www.idf.org/webdata/docs/Metabolic_Syndrome_Definition.pdf.
  • Kahn, R. et al. (2005) American Diabetes Association; European Association for the Study of Diabetes. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 28: 2289—2330.[Abstract/Free Full Text]
  • Kaplan, N.M. (1989) The deadly quartet. Upper—body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Arch Intern Med 149: 1514—1522.[Abstract]
  • Kempf, K. et al. (2006) Inflammation in metabolic syndrome and type 2 diabetes: Impact of dietary glucose. Ann NY Acad Sci 1084: 30—48.[Abstract/Free Full Text]
  • Kershaw, E.E. and Flier, J.S. (2004) Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 89: 2548—56.[Abstract/Free Full Text]
  • Kintschner, U. et al. (2007) Irbesartan for the treatment of hypertension in patients with the metabolic syndrome: a sub analysis of the Treat to Target post authorization survey. Cardiovasc Diabetol 36: 12.
  • Kjeldsen, S.E. et al. (2006) Effects of valsartan compared to amlodipine on preventing type 2 diabetes in high—risk hypertensive patients: the VALUE trial. J Hypertens 24: 1405—1412.[Medline] [Order article via Infotrieve]
  • Kunze, D.L. et al. (2007) Hypertension in sleep apnea: the role of the sympathetic pathway. Cleve Clin J Med 74: S34—36.[Medline] [Order article via Infotrieve]
  • Lee, Y.H. and Pratley, R.E. (2005) The evolving role of inflammation in obesity and the metabolic syndrome. Curr Diab Rep 5: 70—75.[Medline] [Order article via Infotrieve]
  • Leslie, B.R. (2005) Metabolic syndrome: historical perspectivas. Am J Med Sci 330: 264—268.[CrossRef][Medline] [Order article via Infotrieve]
  • Meisinger, C. et al. (2006) Metabolic syndrome: older than usually assumed, but still too young to die. Clin Chem 52: 897—898.[Free Full Text]
  • Minsal (2003) Encuesta Nacional de Salud, Chile 2003. Available at: http://epi.minsal.cl/epi/html/invest/ENS/ENS.htm.
  • National Cholesterol Education Program (2001 ) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults. Executive summary of the Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III) (2001) J Am Med Assoc 285: 2486—2497.[Free Full Text]
  • Negro, R. et al. (2004) Pioglitazone reduces blood pressure in non—dipping diabetic patients. Minerva Endocrinol 29: 11—17.[Medline] [Order article via Infotrieve]
  • Negro, R. et al. (2005) Rosiglitazone effects on blood pressure and metabolic parameters in nondipper diabetic patients. Diabetes Res Clin Pract 70: 20—25.[CrossRef][Medline] [Order article via Infotrieve]
  • Ong, K.L. et al. (2007) Prevalence, Awareness, Treatment, and Control of Hipertensión Among United Status Adults 1999—2004. Hypertension 49: 69—75.[Abstract/Free Full Text]
  • Raikkonen, K. et al. (2007) Depressive symptoms and stressful life events predict metabolic syndrome among middle—aged women: a comparison of World Health Organization, Adult Treatment Panel III, and International Diabetes Foundation definitions. Diabetes Care 30: 872—877.[Abstract/Free Full Text]
  • Reaven, G. (1988) Role of insulin resistance in human disease. Diabetes 37: 1595—1607.[Abstract]
  • Reaven, G.M. (1993) Role of insulin resistance in human disease (syndrome X): an expanded definition. Annu Rev Med 44: 121—123.[CrossRef][Medline] [Order article via Infotrieve]
  • Reaven, G.M. (1995) Pathophysiology of insulin resistance in human disease. Physiol Rev 75: 473—486.[Abstract/Free Full Text]
  • Reaven, G.M. (2005) The metabolic syndrome: requiescat in pace. Clin Chem 51: 931—938.[Abstract/Free Full Text]
  • Reaven, G.M. (2006) The metabolic syndrome: is this diagnosis necessary? Am J Clin Nutr 83: 1237—1247.[Abstract/Free Full Text]
  • Roberts, A.W. and Evans, M. (2004) The metabolic syndrome, inflammation and cardiovascular disease in type 2 diabetes. Curr Opin Lipidol 15: 89—91.[CrossRef][Medline] [Order article via Infotrieve]
  • Sarafidis, P.A. and Nilsson, P.M. (2006) The metabolic syndrome: a glance at its history. J Hypertens 24: 621—626.[Medline] [Order article via Infotrieve]
  • Simons, L.A. et al. (1998) Effects of atorvastatin monotherapy and simvastatin plus cholestyramine on arterial endothelial function in patients with severe primary hypercholesterolaemia. Atherosclerosis 137: 197—203.[CrossRef][Medline] [Order article via Infotrieve]
  • Stout, R.W. (1991) Insulin as a mitogenic factor: role in the pathogenesis of cardiovascular disease. Am J Med 90: 62S—65S.[Medline] [Order article via Infotrieve]
  • Stout, R.W. (1992) Insulin and atherogenesis. Eur J Epidemiol (Suppl 1): 134—135.
  • Thomas, G.N. et al. (2000) Obesity, independent of insulin resistance, is a major determinant of blood pressure in normoglycemic Hong Kong Chinese. Metabolism 49: 1523—1528.[CrossRef][Medline] [Order article via Infotrieve]
  • WHO Collaborating Centre for Drug Statistics Methodology (2007) Available at: http://www.whocc.no/atcddd/atcsystem.html.
  • Wofford, M.R. et al. (2004) Pathophysiology and treatment of obesity hypertension. Curr Pharm Des 10: 3621—3637.[CrossRef][Medline] [Order article via Infotrieve]

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?



This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Margozzini, P.
Right arrow Articles by Valdés, G.
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?